4.4 Article

Racial-Ethnic Disparities in Diabetes Technology Use Among Young Adults with Type 1 Diabetes

Journal

DIABETES TECHNOLOGY & THERAPEUTICS
Volume 23, Issue 4, Pages 306-313

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/dia.2020.0338

Keywords

Young adults; Type 1 diabetes; Technology; Insulin pump; Continuous glucose monitor; Health care disparities; Inequity

Funding

  1. National Institute of Diabetes and Digestive Kidney Diseases [K23DK115896, P-30DK111022]
  2. Leona M. and Harry B. Helmsley Charitable Trust pilot award through the T1D Exchange

Ask authors/readers for more resources

Recent studies have found significant racial-ethnic disparities in insulin pump and continuous glucose monitor use among people with type 1 diabetes, with socioeconomic status not being the sole driver of these disparities. Future research should focus on minority young adults' preferences and issues within the medical system to explain these differences.
Background: Recent studies highlight racial-ethnic disparities in insulin pump and continuous glucose monitor (CGM) use in people with type 1 diabetes (T1D), but drivers of disparities remain poorly understood beyond socioeconomic status (SES). Methods: We recruited a diverse sample of young adults (YA) with T1D from six diabetes centers across the United States, enrolling equal numbers of non-Hispanic (NH) White, NH Black, and Hispanic YA. We used multivariate logistic regression to examine to what extent SES, demographics, health care factors (care setting, clinic attendance), and diabetes self-management (diabetes numeracy, self-monitoring of blood glucose, and Self-Care Inventory score) explained insulin pump and CGM use in each racial-ethnic group. Results: We recruited 300 YA with T1D, aged 18-28 years. Fifty-two percent were publicly insured, and the mean hemoglobin A1c was 9.5%. Large racial-ethnic disparities in insulin pump and CGM use existed: 72% and 71% for NH White, 40% and 37% for Hispanic, and 18% and 28% for NH Black, respectively. After multiple adjustment, insulin pump and CGM use remained disparate: 61% and 53% for NH White, 49% and 58% for Hispanic, and 20 and 31% for NH Black, respectively. Conclusions: Insulin pump and CGM use was the lowest in NH Black, intermediate in Hispanic, and highest in NH White YA with T1D. SES was not the sole driver of disparities nor did additional demographic, health care, or diabetes-specific factors fully explain disparities, especially between NH Black and White YA. Future work should examine how minority YA preferences, provider implicit bias, systemic racism, and mistrust of medical systems help to explain disparities in diabetes technology use.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available